TRPV1 and early-onset autosomal dominant Alzheimer disease: Interestingly, TRPV1 expression is reduced in a transgenic model of Alzheimer’s Disease (AD; Du et al., 2020), which is a neurodegenerative disorder characterized by memory and learning deficits.